<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BECA2763-0902-40AA-8DB2-836A5731CF58"><gtr:id>BECA2763-0902-40AA-8DB2-836A5731CF58</gtr:id><gtr:name>Brunel University</gtr:name><gtr:address><gtr:line1>Brunel University</gtr:line1><gtr:line4>Uxbridge</gtr:line4><gtr:line5>Middlesex</gtr:line5><gtr:postCode>UB8 3PH</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/49D4DD28-1EE4-4871-9639-634CD80D22AE"><gtr:id>49D4DD28-1EE4-4871-9639-634CD80D22AE</gtr:id><gtr:firstName>Holger</gtr:firstName><gtr:surname>Hummerich</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/532E300C-FFFF-4B5D-BCC4-C48D2A2F889C"><gtr:id>532E300C-FFFF-4B5D-BCC4-C48D2A2F889C</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Mead</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U123160651"><gtr:id>78F361BB-C11C-4DE3-98A5-2A1F3764394F</gtr:id><gtr:title>Genetics, Epigenetics and Bioinformatics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U123160651</gtr:grantReference><gtr:abstractText>Human molecular genetics|Most of the UK population has been exposed to Bovine Spongiform Encephalopathy (BSE, commonly known as mad cow disease) by eating contaminated food. The germ that causes BSE, called a prion, may infect humans, resulting in a fatal brain illness called variant Creutzfeldt-Jakob disease (vCJD). While there are few patients to date, we do not know how many might be infected with the disease and develop symptoms later. |vCJD has so far only affected one genetic subtype of individual, found in 40% of healthy people in the UK. Whether other genetic types will become affected, and if so whether they will have an illness like vCJD is unknown. It is clear that genes are important in controlling who will get vCJD. To study this we are using modern technologies to measure many hundreds of thousands of different genetic types, and compare these between groups of the healthy population and vCJD patients.|We are also developing and applying methods to extract, combine and make sense of the huge amount of genetic and other information which is generated by scientists working in the field of molecular biology and Prion research around the world.|Bioinformatics|We are developing and applying methods to extract, combine and make sense of the huge amount of data which is generated by scientists working in the field of molecular biology and Prion research around the world. This includes large sets of data generated by us in the Prion Unit, towards furthering our understanding of the underlying principles of Prion disease. We are able to do this through information technology and the use of fast computers, software programs for analysis and access to data via the internet.</gtr:abstractText><gtr:technicalSummary>The MRC Prion Unit Human Molecular Genetics of Prion and Related Dementias Programme investigates why some people, but not others, get prion diseases such as Creutzfeldt-Jakob disease (CJD). By comparing genetic differences between people who developed CJD and healthy people we hope to identify genes that influence why particular people are more susceptible to these diseases, and use this information to better estimate public health risks and to develop new tests and treatments. We also know that the fundamental processes involved in CJD, where one of the bodys own proteins becomes misshapen and then forms large clumps of material, are very relevant to other much commoner diseases such as Alzheimers Disease. ||Evidence in support of the involvement of non- PRNP genetic factors comes in part from work with laboratory inbred mouse strains, detailed in this groups section. A small number (~5) of quantitative trait loci (QTL) responsible for determining incubation time following intra-cerebral inoculation with prions have been mapped by the MRC Prion Unit and others using different crossing strategies and prion strains. The integration of unbiased genome-wide strategies in mouse and human prion disease will be an important in the success of both programs. Our discovery research utilises recently available genome-wide genotyping technologies. We have successfully conducted a pilot genome-wide association study with EA-Affymetrix 500K arrays (Mead et al. Lancet Neurology 2009). The necessary molecular genetic, bioinformatic, and statistical genetic expertise for genome-wide association study is either available in the Unit or through collaboration. Over the next few years we expect to develop our discovery genome-wide association research in larger patient cohorts using more advanced genotyping technologies, and focus on developing cellular and animal models to test the genes identified in our discovery research. It has become increasingly apparent that neurodegenerative diseases share fundamental mechanisms involving protein misfolding, including Alzheimers disease and Parkinsons disease. It is likely that genetic modifiers of prion pathogenesis may be of broader relevance to other protein misfolding diseases, and we intend to explore these possibilities.|One of the key goals of bioinfomatics in the Unit is to identity modifier genes, pathways and mechanisms controlling prion pathogenesis. The objective of this aspect of the programme is to use computational and statistical methods for the analysis and integration of these Unit based large-scale experiments (and also externally generated data sets) and their resulting data sets, which are large, inherently noisy and do not produce necessarily clear candidates.</gtr:technicalSummary><gtr:fund><gtr:end>2017-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>13128410</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Non-prion dementia genetics prinicpally frontotemporal lobar degeneration, but others</gtr:description><gtr:id>CAFB68A7-D6C9-4E57-9F5E-C6DF8F29FDB2</gtr:id><gtr:impact>28229125
27899424
27581216
26362910
26041104
25662776
25638642
25595499
25160042
24943344
24521566
24510641
24442578
24286341
23998997
23904625
23818065
23649896
23434116
23006986
22406228
22366791
21908872
21849340
21387114
21257233
20490813
20045477
19884572
19864668
19679189
19446372
19217189
18648346
18413474
18234697
16969862
27777022
27524508
26490334
26079503
25959826
25778476
25160042
24162737
23724096
23649896
23150934
23148125
22406228
22027014
22005930
21460840
21193246
21085570
20583301
20209083</gtr:impact><gtr:outcomeId>2EB29C6440E-1</gtr:outcomeId><gtr:partnerContribution>Clinical data and sample from patients with various neurodegenerative diseases</gtr:partnerContribution><gtr:piContribution>Genetic analyses, sample archiving and distribution</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>Statistical Genetics</gtr:description><gtr:id>75B0E5A3-5104-4BD5-9B32-AA6BB71D5456</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>531F52F6A9D-1</gtr:outcomeId><gtr:partnerContribution>Genome wide genetic data including exomes, genomes</gtr:partnerContribution><gtr:piContribution>Plans to send genome sequencing data for their support in analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuropsychiatric Genetics and Genomics</gtr:department><gtr:description>Alzheimer's disease GWAS</gtr:description><gtr:id>794ACBB6-81E0-4AFB-B84D-ADB0A6232BA6</gtr:id><gtr:impact>26490334
26079503
25778476
25533204
24922517
24231519
24162737
23724096
23193196
23150934
23148125
22693153
22445811
22442439
22405046
22027014
22005930
21812096
21460840
21085570</gtr:impact><gtr:outcomeId>78EFE3064D4-1</gtr:outcomeId><gtr:partnerContribution>Alzheimer's disease GWAS</gtr:partnerContribution><gtr:piContribution>Contribution of Alzheimer's disease samples to ongoing GWAS in GERAD, IGAP, PERADES and other funded collaborations led by Cardiff University</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brunel University London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Information Systems, Computing and Mathematics</gtr:department><gtr:description>Data integration</gtr:description><gtr:id>69DC3292-1D3E-4431-8B11-A1C2A58B9EAA</gtr:id><gtr:impact>nothing yet</gtr:impact><gtr:outcomeId>GnNWJa1xX6m-1</gtr:outcomeId><gtr:piContribution>Data integration collaboration in terms of Prion disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Papua New Guinea Institute of Medical Research</gtr:collaboratingOrganisation><gtr:country>Papua New Guinea, Independent State of</gtr:country><gtr:description>Genetic studies of populations in the Eastern Highlands Province of Papua New Guinea</gtr:description><gtr:id>F9B3833D-AA75-4F66-8D4D-446AE75C4E47</gtr:id><gtr:impact>26061765
25726360
22210626
19923577
19214206
19081515
18849290
18849289
16798390
12690204</gtr:impact><gtr:outcomeId>58c139f5224419.30264284-1</gtr:outcomeId><gtr:partnerContribution>Access to samples and local knowledge</gtr:partnerContribution><gtr:piContribution>Genetic studies</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>National Prion Clinic Open Days</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>99ABEC7A-2DDA-449D-B452-55F0957BF293</gtr:id><gtr:impact>3 hours sited at the MRC Prion Unit Several meetings in a year to patient groups, usually 10-40 attendees.

Positive feedback from the process</gtr:impact><gtr:outcomeId>40DD0EA12CB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centenial and other annual Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8F7BAE86-481F-4AC3-9E40-168CDE6B10E0</gtr:id><gtr:impact>Over 100 attendees including MPs, health professionals, patients, national media, TV interview was done with Director

Exclusive interview on Channel 4 news</gtr:impact><gtr:outcomeId>R6HbSK67jnJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.nationalprionclinic.org</gtr:url><gtr:year>2013,2014,2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press releases about papers</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8042B8DC-2D6B-410E-8525-8A27461BD3A7</gtr:id><gtr:impact>Major publications are accompanied by press releases, for example in 2013 we issued press releases regarding the development of Southern Blotting technology and the MRC Dementia Gene Panel

Often widely disseminated in the press</gtr:impact><gtr:outcomeId>13E7D7458A3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference presentations</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>45C2EB6D-99FB-4893-AB76-0B8DE2340B1A</gtr:id><gtr:impact>Many each year, often platform presentations, most recently invited to talk at PRION2017, and at ABN annual meeting in London 2016

n/a</gtr:impact><gtr:outcomeId>5635AC47631</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL UCLH Comprehensice Biomedical Centre</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>624FBA61-E4F6-4C04-9A85-F7C1DD2BA7CC</gtr:id><gtr:outcomeId>6DA0304CF670</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCLH BRU</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C434F274-9800-4335-B3BE-87A6C6BEC337</gtr:id><gtr:outcomeId>EFcNAtpyL6m</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>mrc prion disease research fund</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A8F2B2E4-2B63-4B44-A93C-62FFFF3A8DD0</gtr:id><gtr:outcomeId>58c13c5f47f495.54484134</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>165000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CHDI research award</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:id>EC504244-1458-4BC5-B082-1B40AD63212F</gtr:id><gtr:outcomeId>58c13c06d0c562.26214546</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>568000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust WTCCC (Genome-wide study of human prion disease)</gtr:description><gtr:end>2010-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>14BB0EF6-DE18-42AD-BDD3-F2907C8FC5AE</gtr:id><gtr:outcomeId>A223D3523310</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Committee attendance</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6A615D94-B12D-4D5A-9D4A-31D544359A70</gtr:id><gtr:impact>Development of a national strategy to protect the public from the risks of prion disease transmission through surgical instruments and blood/blood product transfusion</gtr:impact><gtr:outcomeId>ApsfKV58eC7</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Genotyping of appendices for Health Protection Agency study</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>DD35BD2C-A43C-4A65-BA5B-04672F508FC1</gtr:id><gtr:outcomeId>JCfXBS2yqrh</gtr:outcomeId><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>A method to accurately detect and size a large genetic mutation which previously was very hard to diagnose</gtr:description><gtr:id>81F28143-6042-4FD1-9C42-4A952ABDD930</gtr:id><gtr:impact>Will be licensed to a major US diagnostics company</gtr:impact><gtr:outcomeId>V5HG9oNMxn9</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Southern Blot technology in C9orf72</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A technology to diagnose all known genetic causes of dementia in a one-step cost effective manner using next generation sequencing technology</gtr:description><gtr:id>F44F6243-C5A8-4196-8E88-D6C8424BF43E</gtr:id><gtr:impact>Improved diagnostic accuracy in dementia</gtr:impact><gtr:outcomeId>FkNZeSZ35AT</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>The MRC Dementia Gene Panel</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>https://www.ampliseq.com/protected/tmpl/verifiedPanelsDashboard.action?tmplDesignType=COMMUNITY_PANEL</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>75E9E5DB-7CE5-4FDE-9D0A-B82D41D816E2</gtr:id><gtr:title>Ascertainment bias causes false signal of anticipation in genetic prion disease.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1883c4db6133e134f16c49b17a524b13"><gtr:id>1883c4db6133e134f16c49b17a524b13</gtr:id><gtr:otherNames>Minikel EV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5450a91a4ba759.32681397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACF495A5-BEEF-4EDA-A760-DEE6782C0B98</gtr:id><gtr:title>A novel prion protein variant in a patient with semantic dementia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4eddb0cc7499466ab802a8e6d83d23b"><gtr:id>f4eddb0cc7499466ab802a8e6d83d23b</gtr:id><gtr:otherNames>Kenny J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa3dc61e1ac08.85520394</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF1AADAB-B12C-4FDF-9C91-1F572EA827AE</gtr:id><gtr:title>A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer's disease</gtr:title><gtr:parentPublicationTitle>European Journal of Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f18ac2878a1c2e080546c2a6b4d7b69"><gtr:id>3f18ac2878a1c2e080546c2a6b4d7b69</gtr:id><gtr:otherNames>Knight W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn><gtr:outcomeId>47148E27125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B9FA1E3-2EC9-40E7-8605-E3D362AB4517</gtr:id><gtr:title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_14716_26_22406228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AE97356-B269-4C60-BA71-39671699B6C9</gtr:id><gtr:title>Collinge et al. reply.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58c12fe1473833.39074820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EA38EFF-3B84-472B-B118-3201516B66FF</gtr:id><gtr:title>Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>56ddabc32da126.19881538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A2C3753-120B-4803-A979-76A131477B15</gtr:id><gtr:title>Genetic analysis of the cytoplasmic dynein subunit families.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/052a1f2520918d31e8c8a064ecba6e63"><gtr:id>052a1f2520918d31e8c8a064ecba6e63</gtr:id><gtr:otherNames>Pfister KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>3FEF306882A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4CB7D3E-6CC1-400E-BC74-CF5F3DB32C2C</gtr:id><gtr:title>Genetics of prion disease.</gtr:title><gtr:parentPublicationTitle>Topics in current chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f77f35fd10f11cc2beec3df854647449"><gtr:id>f77f35fd10f11cc2beec3df854647449</gtr:id><gtr:otherNames>Lloyd S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-1022</gtr:issn><gtr:outcomeId>kFXAzD9xebn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F1B3413-0944-405C-80A1-39A4DCA29F5F</gtr:id><gtr:title>Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e65ad8ad8d99155072e5805168e305c6"><gtr:id>e65ad8ad8d99155072e5805168e305c6</gtr:id><gtr:otherNames>Lee SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14716_26_23193196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A712464-4F22-457B-873D-F19B5C93F857</gtr:id><gtr:title>A highly specific blood test for vCJD.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d35fcc5cee51bf10673b89f590a94d4a"><gtr:id>d35fcc5cee51bf10673b89f590a94d4a</gtr:id><gtr:otherNames>Jackson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5450a91e26d8e9.08373405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9075A773-993B-4818-93B3-5AC73B0CA58B</gtr:id><gtr:title>Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f50f494061631e387b397ef9e7255462"><gtr:id>f50f494061631e387b397ef9e7255462</gtr:id><gtr:otherNames>Zou F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14716_26_23724096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF93387F-6BCA-4E0C-A28B-05F9D4F68DB9</gtr:id><gtr:title>Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b0f71bff1be428cd8369af4da4057398"><gtr:id>b0f71bff1be428cd8369af4da4057398</gtr:id><gtr:otherNames>?stergaard SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56ddabc4608cc2.85308919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5703905B-F5C2-435B-A1C1-6ECE134DABBD</gtr:id><gtr:title>Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14716_26_22210626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF6C9C4B-A026-4BA3-A264-1A163F3FF5E1</gtr:id><gtr:title>Small deletion in C9orf72 hides a proportion of expansion carriers in FTLD.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56ddabc389c011.34861060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A048BD89-3121-4F25-801A-7C0E0C8A4C64</gtr:id><gtr:title>Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5450a91bb4b474.56240550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADCC7377-E4DF-4A1A-A96D-34BC132C7B11</gtr:id><gtr:title>Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244cc363f830eda2f51ecf6bac87f6f0"><gtr:id>244cc363f830eda2f51ecf6bac87f6f0</gtr:id><gtr:otherNames>Hensman Moss DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5aa3dc61aba8b0.46338674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51D8C97B-D021-447D-B726-404B48E180DA</gtr:id><gtr:title>Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b20fe581f807c3e4e12bea8541550d02"><gtr:id>b20fe581f807c3e4e12bea8541550d02</gtr:id><gtr:otherNames>Luk C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58c12fe00b1393.75598873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDB11723-2CC7-4341-924D-BAB1F3A66CA5</gtr:id><gtr:title>HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>6CED242B796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D25DB61-4420-4CEB-8434-EADBFC16ACAA</gtr:id><gtr:title>Predictive testing for inherited prion disease: report of 22 years experience.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d47ad451beb379d16b15c48e905cf90"><gtr:id>9d47ad451beb379d16b15c48e905cf90</gtr:id><gtr:otherNames>Owen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>5450a91c2f87b0.55685377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69CEF79E-7068-4A2C-9595-9816ADA477F8</gtr:id><gtr:title>Collinge et al. reply.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58c12fe0410b75.10880238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2AAA8F4-9414-44DC-8660-BDA354BA29CE</gtr:id><gtr:title>Altered body schema processing in frontotemporal dementia with C9ORF72 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62492dde95d7bf93142132ffcca5319f"><gtr:id>62492dde95d7bf93142132ffcca5319f</gtr:id><gtr:otherNames>Downey LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5450a91d156956.32607305</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA31FAB6-A0B0-4DE1-BD12-E215C323A3F3</gtr:id><gtr:title>Molecular diagnosis of human prion disease.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>CF8ABA7B6F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41D94373-ED72-48BF-AE5D-7748E1FA293E</gtr:id><gtr:title>Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>0847C254990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>576100E2-366F-4075-BD18-0E8E2A4F110C</gtr:id><gtr:title>Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48400a296d38fca43225c28bd85f67c0"><gtr:id>48400a296d38fca43225c28bd85f67c0</gtr:id><gtr:otherNames>Reiniger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5450a91f16e552.22867770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16ED5B69-0875-499F-AB21-AC0EEDBF7861</gtr:id><gtr:title>Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecb95f24c0e9454b353263ea6230fa92"><gtr:id>ecb95f24c0e9454b353263ea6230fa92</gtr:id><gtr:otherNames>Webb TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>02BEE66206A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E747BB0D-FC97-4E7B-B30B-1CDDC7562BA0</gtr:id><gtr:title>The heritability and genetics of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>BDA2E804223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>612F891C-E310-4CBD-991C-DA7F4570EEDD</gtr:id><gtr:title>Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3d9dd16ce35d2096b37dfc9199bc7"><gtr:id>69c3d9dd16ce35d2096b37dfc9199bc7</gtr:id><gtr:otherNames>Hamilton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14716_26_22405046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF9A0ADC-47C7-4F16-83B1-323B199EC579</gtr:id><gtr:title>Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58c12fe1ee4160.64678917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0674BD8F-D820-49E1-A0B2-261A6F6496A7</gtr:id><gtr:title>Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5450a91aac98a5.95136419</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69D3E49C-43CB-4C72-85FE-E085849B16A1</gtr:id><gtr:title>Inherited mtDNA variations are not strong risk factors in human prion disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56ddabc242da09.20368870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DBC7520-E880-4C86-ADB1-AD07881DA876</gtr:id><gtr:title>Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>gSQd4JLnXqa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F44292AD-9838-422A-9E99-F16251F40E5B</gtr:id><gtr:title>A new prion disease: relationship with central and peripheral amyloidoses.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>56ddabc156a0b7.00631187</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EB8D085-5205-47F8-8A65-D486629F690B</gtr:id><gtr:title>Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71580ef822aa97e50703ee41546f9747"><gtr:id>71580ef822aa97e50703ee41546f9747</gtr:id><gtr:otherNames>Alner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>r3L8nT3a8rg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D691C386-7B95-4611-B9AD-DB603A2B17D0</gtr:id><gtr:title>Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c21ca207c819acc81fdee427916113"><gtr:id>07c21ca207c819acc81fdee427916113</gtr:id><gtr:otherNames>Gill ON</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5450a91fde6ed9.75405627</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2CE91CA-FF38-4C09-BDB1-3D036BE6E80A</gtr:id><gtr:title>Behavioral and psychiatric symptoms in prion disease.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b2e606c7abd26ebb7b86026fa391727"><gtr:id>8b2e606c7abd26ebb7b86026fa391727</gtr:id><gtr:otherNames>Thompson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>5450a91ca53ed2.98107664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>767F7081-763B-42D9-B387-A8D320CCAA1A</gtr:id><gtr:title>Autoantibodies in sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b741ada569a250435aca20c3646d362"><gtr:id>9b741ada569a250435aca20c3646d362</gtr:id><gtr:otherNames>Angus-Leppan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_14716_26_23699783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9588997F-D0D8-45B5-815D-2276521480C7</gtr:id><gtr:title>Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>7DB014E2A43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FB75ED9-5434-47E8-B1FE-2700738F25BD</gtr:id><gtr:title>Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>EW1yEMZkF1v</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>034A7A0F-1784-4E1C-B0C8-50282E3225C4</gtr:id><gtr:title>No consistent evidence for association between mtDNA variants and Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14716_26_22442439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19A0E7B3-B0B8-4510-A95B-78A91A4B1D31</gtr:id><gtr:title>Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_14716_26_23434116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF8C4C72-14CC-4A69-9B03-722791604D23</gtr:id><gtr:title>How does the genetic assassin select its neuronal target?</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>VQVMWmJapY4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58C27186-5116-48FF-B699-4759052F3651</gtr:id><gtr:title>Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS).</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a2c27e62e42f495e188725f3e1be5c4"><gtr:id>9a2c27e62e42f495e188725f3e1be5c4</gtr:id><gtr:otherNames>Shi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14716_26_22445811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2928CD6C-44D9-40E4-858A-AC59D3406A4D</gtr:id><gtr:title>Kuru in the 21st century--an acquired human prion disease with very long incubation periods.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>4D7C46D7FAC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69B7E871-C7BE-49A1-A33B-966AF9792538</gtr:id><gtr:title>Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>FA69FBB14DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>082CB9E7-D3BC-4E8D-81BD-7AC1E1C6DEE9</gtr:id><gtr:title>Successful amplification of degraded DNA for use with high-throughput SNP genotyping platforms.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>B83C7A08668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6426E146-5428-47D4-BE65-B7370766C4BE</gtr:id><gtr:title>A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer's disease risk.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028d3b2ceed7be9c07d74b670071bc7f"><gtr:id>028d3b2ceed7be9c07d74b670071bc7f</gtr:id><gtr:otherNames>Chapman J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14716_26_23148125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C95E226-AF98-4229-A48D-E0442A564771</gtr:id><gtr:title>Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56ddabc2afe9f8.02641501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CB37C28-E899-450B-9887-0769A9A238BA</gtr:id><gtr:title>Mapping the progression of progranulin-associated frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1745-834X</gtr:issn><gtr:outcomeId>A6677187BE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2030CA7C-633A-481C-9C98-E81248BEF94B</gtr:id><gtr:title>Imaging and CSF analyses effectively distinguish CJD from its mimics.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01510dcd2c16ce1aeba88470243237a4"><gtr:id>01510dcd2c16ce1aeba88470243237a4</gtr:id><gtr:otherNames>Rudge P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa3dc60f17342.44237573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8CEF95-62C5-499B-A40F-6A936094267E</gtr:id><gtr:title>Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>1C4CF1179FB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EA3551B-1C18-4E59-8A2A-75D1B1C48B63</gtr:id><gtr:title>Erratum: Evidence for human transmission of amyloid-? pathology and cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46f5fbd4a8def22591a116738bda4515"><gtr:id>46f5fbd4a8def22591a116738bda4515</gtr:id><gtr:otherNames>Jaunmuktane Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56ddabc28f20f6.60504769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E6D0C09-B471-471C-BDEA-C9AF17426B0D</gtr:id><gtr:title>Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9310cf284c8313db35d3785d3e32077"><gtr:id>a9310cf284c8313db35d3785d3e32077</gtr:id><gtr:otherNames>Harold D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>465DB6CC595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80726F73-0793-47CD-B043-54C6250D89A7</gtr:id><gtr:title>Genetic variability in CLU and its association with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f54cad0ab0877e543fc660186cd44ff0"><gtr:id>f54cad0ab0877e543fc660186cd44ff0</gtr:id><gtr:otherNames>Guerreiro RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>fLwjrrnC8zJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B457917C-0BC3-47BC-B532-ABD70D6A3D15</gtr:id><gtr:title>The presenilin 1 P264L mutation presenting as non-fluent/agrammatic primary progressive aphasia.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_14716_26_23579325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCE90288-5ADF-4372-84E2-AB55439C0C58</gtr:id><gtr:title>A novel protective prion protein variant that colocalizes with kuru exposure.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>50E5CD17FD9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>038E4C3F-F3BF-4305-9243-908DE99120EC</gtr:id><gtr:title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aa3dc6157d029.21110556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65EC0707-24D9-44CD-A873-3624ABF43BD6</gtr:id><gtr:title>Genetic susceptibility, evolution and the kuru epidemic.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>E46FED6FC78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A71C758-59AA-43C8-B0F2-256653C9E25B</gtr:id><gtr:title>Evidence of amyloid-? cerebral amyloid angiopathy transmission through neurosurgery.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46f5fbd4a8def22591a116738bda4515"><gtr:id>46f5fbd4a8def22591a116738bda4515</gtr:id><gtr:otherNames>Jaunmuktane Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5aa3dc6037ced3.82454431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A40AFAC5-25AC-42BD-B92B-A3C1B885CCAC</gtr:id><gtr:title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07e74972561be40ab721f911617b3191"><gtr:id>07e74972561be40ab721f911617b3191</gtr:id><gtr:otherNames>Lambert JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5450a91fafd5e9.65804100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BA0FBA2-0BA9-4944-A7F2-6EC6661033C7</gtr:id><gtr:title>Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_14716_26_23818065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BEF730E-A83D-4F6E-AFC1-9F869556C54C</gtr:id><gtr:title>HECTD2 is associated with susceptibility to mouse and human prion disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>948E3A2B543</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BA5A1BF-2CC2-4068-BAD3-AFFC0BFFFA4A</gtr:id><gtr:title>Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58c12fdf9248b0.76482545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53F891DB-5BED-4A28-8EEB-4CC58966C794</gtr:id><gtr:title>Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e17a218daa77aa27ae185d2c0fbbe085"><gtr:id>e17a218daa77aa27ae185d2c0fbbe085</gtr:id><gtr:otherNames>Weston PSJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa3dc61231f71.44025137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D41DB74B-6F4F-4FDE-A214-87CEEB7C96E9</gtr:id><gtr:title>Familial prion disease in a Hungarian family with a novel 144-base pair insertion in the prion protein gene.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c381d26f9875b63e5b1452a990e9005"><gtr:id>8c381d26f9875b63e5b1452a990e9005</gtr:id><gtr:otherNames>Kov?cs T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>287F7276769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C26975D-7F37-4DF3-A860-C27B2F5DB30F</gtr:id><gtr:title>Creutzfeld-Jakob disease--reply.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b741ada569a250435aca20c3646d362"><gtr:id>9b741ada569a250435aca20c3646d362</gtr:id><gtr:otherNames>Angus-Leppan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5450a91e988035.24763872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F7F1DEF-3131-4E71-AE9D-343A985B6213</gtr:id><gtr:title>Corticobasal syndrome associated with a novel 1048_1049insG progranulin mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>25E7BF34DA4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2E81B51-D68D-4F9B-841D-38CBF3BB07F3</gtr:id><gtr:title>Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66af904a27f77da84a6a4d64a502057e"><gtr:id>66af904a27f77da84a6a4d64a502057e</gtr:id><gtr:otherNames>McNaughton D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>ifRTFQDv8Su</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CAF4856-124E-4A5E-AC1C-623C1D9A7011</gtr:id><gtr:title>Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3ab405150e2089e42f3d42e7d67f33a"><gtr:id>b3ab405150e2089e42f3d42e7d67f33a</gtr:id><gtr:otherNames>Lashley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56ddabc2073907.94841437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F429FA28-39C1-4A49-9640-807CBC5703BB</gtr:id><gtr:title>C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244cc363f830eda2f51ecf6bac87f6f0"><gtr:id>244cc363f830eda2f51ecf6bac87f6f0</gtr:id><gtr:otherNames>Hensman Moss DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5450a91e603903.14679051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C8A14EE-5256-45A0-B9C4-4B90C8E322F2</gtr:id><gtr:title>Convergent genetic and expression data implicate immunity in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1229498ce393fd300290a6e5f48128bf"><gtr:id>1229498ce393fd300290a6e5f48128bf</gtr:id><gtr:otherNames>International Genomics of Alzheimer's Disease Consortium (IGAP)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>56ddabc3536b61.97205678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A394BDE-CCB2-4FA2-9876-08B6AEF8CB20</gtr:id><gtr:title>CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5fd1a5ff40074b24ae4f2f71e988b0"><gtr:id>1d5fd1a5ff40074b24ae4f2f71e988b0</gtr:id><gtr:otherNames>Abdelkarim S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56ddabc26d76e9.27405586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4CC7DAD-FBF3-4055-9471-E386BA6CDE91</gtr:id><gtr:title>Quantitative EEG parameters correlate with the progression of human prion diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93cdbb2f82402ae3559e93ad831c327b"><gtr:id>93cdbb2f82402ae3559e93ad831c327b</gtr:id><gtr:otherNames>Franko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58c12fe116c2c5.27868707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CD22EAA-3ACC-42D7-A07F-9BDAB78E2EE5</gtr:id><gtr:title>The TMEM106B risk allele is associated with lower cortical volumes in a clinically diagnosed frontotemporal dementia cohort.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a87065ddaaf919be66ca0e35421554c"><gtr:id>6a87065ddaaf919be66ca0e35421554c</gtr:id><gtr:otherNames>Harding SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa3dc621a2039.28495849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38EF6747-D90A-41C8-B4D7-AD920B2F2805</gtr:id><gtr:title>Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425c10daa4923f9040e1a5332915e6e"><gtr:id>2425c10daa4923f9040e1a5332915e6e</gtr:id><gtr:otherNames>Kaski DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>aqQR6SLKjEk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC071626-68D7-4E1C-99CE-64880673367D</gtr:id><gtr:title>MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5c31182cd1a4acdea4acac66e5ce433"><gtr:id>c5c31182cd1a4acdea4acac66e5ce433</gtr:id><gtr:otherNames>Carswell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>pm_14716_26_23216655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>063397CA-89F2-403C-BA7D-4E2CC953FD9A</gtr:id><gtr:title>Genetics of prion diseases.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_14716_26_23518043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA43CBB0-8280-4B67-B231-8BD8EBD2F106</gtr:id><gtr:title>Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international study.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb87f110bb4914af0973f4d8272af1b6"><gtr:id>bb87f110bb4914af0973f4d8272af1b6</gtr:id><gtr:otherNames>Balendra R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>58c12fe18e1fe8.09204454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>022503C7-CE36-4AE6-B481-2EECC4BE32AD</gtr:id><gtr:title>Recent US Case of Variant Creutzfeldt-Jakob Disease-Global Implications.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efd067aa37c0c184cfdb4c6af39aaafb"><gtr:id>efd067aa37c0c184cfdb4c6af39aaafb</gtr:id><gtr:otherNames>Maheshwari A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>56ddabc419b209.82016642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DBC865C-C5DA-48A3-900D-4B9D64938950</gtr:id><gtr:title>Activation of nuclear factor-kappa B signalling promotes cellular senescence.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/586961fc16d1cc790ff61367e12f061c"><gtr:id>586961fc16d1cc790ff61367e12f061c</gtr:id><gtr:otherNames>Rovillain E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>SHCZZtwjF6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF091101-3463-4015-A589-CDBCBC611D87</gtr:id><gtr:title>Heterozygosity at polymorphic codon 219 in variant creutzfeldt-jakob disease.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44154794c63211aac745864409e98d53"><gtr:id>44154794c63211aac745864409e98d53</gtr:id><gtr:otherNames>Lukic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>JUb746tdb2y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>167E847B-B25B-4058-8208-3BAFD7A90B3E</gtr:id><gtr:title>Blood test for variant Creutzfeldt-Jakob disease--reply.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d35fcc5cee51bf10673b89f590a94d4a"><gtr:id>d35fcc5cee51bf10673b89f590a94d4a</gtr:id><gtr:otherNames>Jackson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5450a91b20e007.60443881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24698D18-7697-4377-A192-F67FA961AA06</gtr:id><gtr:title>Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cffe020f334f357ea016470603b153cb"><gtr:id>cffe020f334f357ea016470603b153cb</gtr:id><gtr:otherNames>Coyle-Gilchrist IT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c12fe1bd69c6.60694112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98C7A098-399D-4035-B0EB-7043AA45F8C0</gtr:id><gtr:title>Use of Diffusion-Weighted Magnetic Resonance Imaging in Sporadic Creutzfeldt-Jakob Disease-Reply.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/102d9843eeefde06c7a21180b72c418b"><gtr:id>102d9843eeefde06c7a21180b72c418b</gtr:id><gtr:otherNames>Eisenmenger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58c12fe0d1fc54.22297977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>739C32D7-0815-480A-A9FA-CC019C8B89DF</gtr:id><gtr:title>Profiles of white matter tract pathology in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Human brain mapping</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1065-9471</gtr:issn><gtr:outcomeId>5450a91d89bc78.62084939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8486D1C-7C23-4CD5-B82E-257969E51650</gtr:id><gtr:title>Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_14716_26_23649896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>014BAC5B-F7B4-4454-803E-E131D46E8E47</gtr:id><gtr:title>Rare structural genetic variation in human prion diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44154794c63211aac745864409e98d53"><gtr:id>44154794c63211aac745864409e98d53</gtr:id><gtr:otherNames>Lukic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56ddabc1a324b2.06626580</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E3228B2-C255-4C09-AC10-D5C7C8E0187C</gtr:id><gtr:title>A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>6C06E20299F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A6707C1-50E6-4C89-9FFD-B81DCF205027</gtr:id><gtr:title>Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7ddc22e04c6f9bc94f5ca63e2f1de34"><gtr:id>c7ddc22e04c6f9bc94f5ca63e2f1de34</gtr:id><gtr:otherNames>Thompson AGB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa3dc600c2de8.63461386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7387C2FA-4B20-41FA-9581-660BCE38161A</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5450a91b84c153.73555926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>420BBD23-56DD-49B0-89DB-154D7CE35261</gtr:id><gtr:title>The role of variation at A?PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/719950cfe57960088e8c4cb5aaf09b14"><gtr:id>719950cfe57960088e8c4cb5aaf09b14</gtr:id><gtr:otherNames>Gerrish A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>io4VccbHwuA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90A98DA6-9FDF-40C7-9C69-98422CBFB6A6</gtr:id><gtr:title>A common single-nucleotide variant in T is strongly associated with chordoma.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dab320e67adfe9b0e8ca673fc32954a"><gtr:id>3dab320e67adfe9b0e8ca673fc32954a</gtr:id><gtr:otherNames>Pillay N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14716_26_23064415</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F55FB550-CF0D-4E72-82BC-E35839C1A296</gtr:id><gtr:title>The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a00619128624465a296dd67279e6d575"><gtr:id>a00619128624465a296dd67279e6d575</gtr:id><gtr:otherNames>Woollacott IO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5450a91d4c5726.65370716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4188AD8-9F49-478D-9FEA-2CC012966306</gtr:id><gtr:title>First report of Creutzfeldt-Jakob disease occurring in 2 siblings unexplained by PRNP mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecb95f24c0e9454b353263ea6230fa92"><gtr:id>ecb95f24c0e9454b353263ea6230fa92</gtr:id><gtr:otherNames>Webb TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>7201F6BAE4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF493B60-C6FF-420B-814C-982AD3F54771</gtr:id><gtr:title>Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retina.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12b97dd9cc14f8294a97e4001216bd4"><gtr:id>f12b97dd9cc14f8294a97e4001216bd4</gtr:id><gtr:otherNames>Sergouniotis PI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_14716_26_22137173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDFD5154-9EAA-4FF4-8450-697767DA4D28</gtr:id><gtr:title>Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ae1aa01433ba23d09fb7de58f533706"><gtr:id>7ae1aa01433ba23d09fb7de58f533706</gtr:id><gtr:otherNames>Newman PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5450a91cd454b1.67476133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8385D7AE-6B39-4AB1-9F49-FEB43E82893F</gtr:id><gtr:title>Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>mn6pCWUKSdS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98015B07-73E0-4C6B-A54C-BDC8BCA6A227</gtr:id><gtr:title>A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3ab405150e2089e42f3d42e7d67f33a"><gtr:id>b3ab405150e2089e42f3d42e7d67f33a</gtr:id><gtr:otherNames>Lashley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5450a91eccceb9.49142182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A47343D0-3B74-4EDE-AB74-BF286EA88D6E</gtr:id><gtr:title>A novel prion disease associated with diarrhea and autonomic neuropathy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>5450a91f7dd8b6.15649770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA737DD4-265A-4B83-B26C-BA154D6151AB</gtr:id><gtr:title>Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21fddf35ac29bc00664bc215f41d896f"><gtr:id>21fddf35ac29bc00664bc215f41d896f</gtr:id><gtr:otherNames>Broce I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5aa3dc6095d5b9.03341628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B4706F1-3F57-4E74-BDC6-F3CAED23A705</gtr:id><gtr:title>Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_14716_26_23006986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EEF6CE2-9AED-44DE-8B60-5CFD11DF6A5D</gtr:id><gtr:title>Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>ZVDBjpaVFj8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B4C3051-CECC-4740-B620-24AC2FA1B4C4</gtr:id><gtr:title>The clinical, neuroanatomical, and neuropathologic phenotype of-associated frontotemporal dementia: A longitudinal case report.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/897d235c34e30e62338fa17ff2c4efa6"><gtr:id>897d235c34e30e62338fa17ff2c4efa6</gtr:id><gtr:otherNames>Koriath CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c12fdeb54d22.79489746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC606539-6FEB-4EE2-BE69-D31A9B3E459D</gtr:id><gtr:title>PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cfdf106876171606d0edeedb5461e8f"><gtr:id>5cfdf106876171606d0edeedb5461e8f</gtr:id><gtr:otherNames>Beck JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>YYVoyC3rHW4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9EAEEE4-CC1C-41D1-883A-0EEE7CF74324</gtr:id><gtr:title>A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>C7F74C1E2EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C5AC32F-691E-4904-B5DB-129031F27C34</gtr:id><gtr:title>R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf9d27315b49ef82e560688874a2dd5"><gtr:id>8cf9d27315b49ef82e560688874a2dd5</gtr:id><gtr:otherNames>Slattery CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>5450a91ae451d8.61115128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2B11B14-9457-4A8F-AD17-77F69626AEE8</gtr:id><gtr:title>Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f043ed1cf2c55a840962d924232b9925"><gtr:id>f043ed1cf2c55a840962d924232b9925</gtr:id><gtr:otherNames>De Vita E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>pm_14716_26_23538406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C77155DB-66C1-4E9A-B515-F0AEAC3A18A9</gtr:id><gtr:title>Quantitative interaction proteomics of neurodegenerative disease proteins.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0f118fe1d7289a14a5998bdd80aaca2"><gtr:id>d0f118fe1d7289a14a5998bdd80aaca2</gtr:id><gtr:otherNames>Hosp F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56ddabc1d13923.27398612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB2349E9-E019-44C8-8209-FEB2E5DD4711</gtr:id><gtr:title>The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c3d9dd16ce35d2096b37dfc9199bc7"><gtr:id>69c3d9dd16ce35d2096b37dfc9199bc7</gtr:id><gtr:otherNames>Hamilton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_14716_26_22693153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B47912A-7327-4D4D-8004-949A89392318</gtr:id><gtr:title>Seven-year discordance in age at onset in monozygotic twins with inherited prion disease (P102L).</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc91402d504020448ea53946ad57bcaa"><gtr:id>fc91402d504020448ea53946ad57bcaa</gtr:id><gtr:otherNames>Webb T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>ED6EDDCCEE5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D289AC58-BBD0-4979-80B6-EB70FB249728</gtr:id><gtr:title>TREM2 variants in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_14716_26_23150934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2CA4978-AC2C-488D-B203-8B95FB386D3B</gtr:id><gtr:title>No evidence that extended tracts of homozygosity are associated with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da89c318f56fc7256d9d74b60d23229"><gtr:id>9da89c318f56fc7256d9d74b60d23229</gtr:id><gtr:otherNames>Sims R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>froo7TJgSqU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CE621E3-B722-47F4-BACB-E7879641BEF2</gtr:id><gtr:title>Common polygenic variation enhances risk prediction for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56ddabc2d42101.14433161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D303392-948B-4F99-B77B-685BA6D601D4</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5450a91db2ee22.72384808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88567721-A215-429F-B7D6-CA06EDCD1803</gtr:id><gtr:title>Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d35fcc5cee51bf10673b89f590a94d4a"><gtr:id>d35fcc5cee51bf10673b89f590a94d4a</gtr:id><gtr:otherNames>Jackson GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5450a91c70cf35.64517037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30604C54-1526-4488-B76F-7E5AD0ECA662</gtr:id><gtr:title>Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>qcnqNn3VvSv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60CE0590-7C0F-4CF1-BE61-42D1F509D460</gtr:id><gtr:title>Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_14716_26_22675081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD2D7502-B0E5-4A35-AE2B-D5DAE88788B7</gtr:id><gtr:title>Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e86547207e717145b8a8421a11f93161"><gtr:id>e86547207e717145b8a8421a11f93161</gtr:id><gtr:otherNames>Grizenkova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14716_26_22869728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1451246C-6043-4571-8704-C356821BC1B1</gtr:id><gtr:title>Validation of next-generation sequencing technologies in genetic diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14716_26_23998997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4C86ECB-C9AC-4D51-B5CC-C66ECE274AD2</gtr:id><gtr:title>No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310bf1b5b3cfcc93127e66670fd761a4"><gtr:id>310bf1b5b3cfcc93127e66670fd761a4</gtr:id><gtr:otherNames>Rollinson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>D20BC94C07C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99B4E56B-E9B6-4A91-BCF9-96108F5CD826</gtr:id><gtr:title>Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>0B42AD0238D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53530ACF-BFDB-47E8-A12A-692444C43875</gtr:id><gtr:title>The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a31927906cffc4c4cbf31a0c8fd63195"><gtr:id>a31927906cffc4c4cbf31a0c8fd63195</gtr:id><gtr:otherNames>Thompson AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_14716_26_23550114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47D04DB1-98FA-4E53-9B0C-EF9C98DAEE53</gtr:id><gtr:title>Late onset hereditary sensory and autonomic neuropathy with cognitive impairment associated with Y163X prion mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf48ee536671db6cf98b13e31af877e"><gtr:id>4cf48ee536671db6cf98b13e31af877e</gtr:id><gtr:otherNames>Themistocleous AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>5450a91a10bcf9.20906875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2E803F9-F5E0-4E72-B774-06084279F359</gtr:id><gtr:title>Prion protein gene M232R variation is probably an uncommon polymorphism rather than a pathogenic mutation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_14716_26_22108575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40774350-D358-456F-A5A3-142EDE294D0C</gtr:id><gtr:title>Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56ddabc175fd41.14986563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27C2EE38-6EF0-4247-81B8-15485CFEFF6C</gtr:id><gtr:title>Plasma tau is increased in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/716b1cd2675981e4baae9339297d943e"><gtr:id>716b1cd2675981e4baae9339297d943e</gtr:id><gtr:otherNames>Foiani MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa3dc6068f547.31264716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B95902C2-7B91-4A05-92B1-6ECC98D0A0EA</gtr:id><gtr:title>Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c12fe06fb635.68483487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9275CB5-C8AE-407C-91C1-1D900B462369</gtr:id><gtr:title>Genomic anatomy of the Tyrp1 (brown) deletion complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24ad0b28e2c31bc399d2e87a1638bdf0"><gtr:id>24ad0b28e2c31bc399d2e87a1638bdf0</gtr:id><gtr:otherNames>Smyth IM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>1B3F633F259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FD5D436-8393-4056-ADAD-08370DB5E65E</gtr:id><gtr:title>Genome wide association studies and prion disease.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44154794c63211aac745864409e98d53"><gtr:id>44154794c63211aac745864409e98d53</gtr:id><gtr:otherNames>Lukic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>guSXiutayeV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F15C84B9-CE93-403D-B7EC-06A5C6673AD7</gtr:id><gtr:title>Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58c12fdfd27f38.62758722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6048B0F4-5F7A-423B-AB80-1759AB88EED5</gtr:id><gtr:title>A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>h8RQVFvVepg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B9FC2A3-4CC0-470F-80A9-53AE3EF6CC0E</gtr:id><gtr:title>Questionnaire to reduce the risk of iatrogenic prion disease transmission.</gtr:title><gtr:parentPublicationTitle>The Journal of hospital infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0195-6701</gtr:issn><gtr:outcomeId>CE78A06EA24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46060828-67E5-45C2-AD07-268A7FA16CDB</gtr:id><gtr:title>A novel Alzheimer disease locus located near the gene encoding tau protein.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e3a671aa40c3ab6ceb98c09b75b6095"><gtr:id>3e3a671aa40c3ab6ceb98c09b75b6095</gtr:id><gtr:otherNames>Jun G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>56ddabc3b5e579.01432304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBAC19C1-5AD8-4512-B160-5812DD66609A</gtr:id><gtr:title>Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f043ed1cf2c55a840962d924232b9925"><gtr:id>f043ed1cf2c55a840962d924232b9925</gtr:id><gtr:otherNames>De Vita E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn><gtr:outcomeId>58c12fdf4b69e2.23712759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EB426C4-627F-4ED1-87FE-0E4D4CAED69A</gtr:id><gtr:title>The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12a3e35a0773314c3afbe39a364c5bee"><gtr:id>12a3e35a0773314c3afbe39a364c5bee</gtr:id><gtr:otherNames>Caine D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa3dc60cc1f08.04744359</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AF07081-0D08-473D-BFA6-E2849D6DCED4</gtr:id><gtr:title>TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/097fa5ac687e318ffb9ff4b6418aefdc"><gtr:id>097fa5ac687e318ffb9ff4b6418aefdc</gtr:id><gtr:otherNames>Gallagher MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5450a91dec8885.94346730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FFB9E80-3820-4ED2-A7A6-989899A93060</gtr:id><gtr:title>Association of a null allele of SPRN with variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cfdf106876171606d0edeedb5461e8f"><gtr:id>5cfdf106876171606d0edeedb5461e8f</gtr:id><gtr:otherNames>Beck JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>8AA5E23D65A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A31CE2EF-6138-4298-94E6-D4BBBDC09B9B</gtr:id><gtr:title>Exome sequencing in a consanguineous family clinically diagnosed with early-onset Alzheimer's disease identifies a homozygous CTSF mutation.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/609865d4dd5b805590a0ed599a30249b"><gtr:id>609865d4dd5b805590a0ed599a30249b</gtr:id><gtr:otherNames>Bras J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c12fe0a2a5f5.51850780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F0DA45B-BAA5-407C-A9CE-653AF753FFAC</gtr:id><gtr:title>Age of onset and death in inherited prion disease are heritable.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecb95f24c0e9454b353263ea6230fa92"><gtr:id>ecb95f24c0e9454b353263ea6230fa92</gtr:id><gtr:otherNames>Webb TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>0ABBF97B3F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E26DA210-6705-40F7-8D1F-FA2EE1862D4D</gtr:id><gtr:title>In vitro screen of prion disease susceptibility genes using the scrapie cell assay.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e14ad7dc46751cc03b82cf6e81f69dc"><gtr:id>9e14ad7dc46751cc03b82cf6e81f69dc</gtr:id><gtr:otherNames>Brown CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5450a91bef0fe0.61056169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE210A29-B3DA-4290-BBB2-C71537971FA8</gtr:id><gtr:title>Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/028989dcafa83dba91c03e918dc57a1d"><gtr:id>028989dcafa83dba91c03e918dc57a1d</gtr:id><gtr:otherNames>Mahoney CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_14716_26_22366791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFF93115-B00A-400B-8897-4DF80D1E079A</gtr:id><gtr:title>Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/809b4086fcbd8d5c1c06308f735111f0"><gtr:id>809b4086fcbd8d5c1c06308f735111f0</gtr:id><gtr:otherNames>Mok T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58c12fdf151877.48086075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCFC4163-4177-4D08-80B0-A650EACF9BE7</gtr:id><gtr:title>Progressive logopenic/phonological aphasia: erosion of the language network.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>C260DB60006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F841E6DF-8106-4A5F-94EA-0B8AD42783E1</gtr:id><gtr:title>Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_14716_26_23904625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBCF6783-6E9B-40F4-9CC2-C4809C8CAC6F</gtr:id><gtr:title>Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>1243D613C77</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E21A93C0-CCF6-4085-A93F-B81BE7D7A683</gtr:id><gtr:title>CJD mimics and chameleons.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>58c12fdee1cac8.01516799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B987CBD2-D124-4C38-8EA3-D68D73936089</gtr:id><gtr:title>Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ee5a13f7d6b0787d4919dd19ba893a"><gtr:id>c5ee5a13f7d6b0787d4919dd19ba893a</gtr:id><gtr:otherNames>Rossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5450a91a7b29d6.38172033</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52B3441E-69B1-45FE-B756-E1D9A21D709E</gtr:id><gtr:title>Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/102d9843eeefde06c7a21180b72c418b"><gtr:id>102d9843eeefde06c7a21180b72c418b</gtr:id><gtr:otherNames>Eisenmenger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>56ddabc307e929.96033761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C8A20B8-AF9D-4EE7-BE31-FBF2F7244B33</gtr:id><gtr:title>Cardiovascular disease contributes to Alzheimer's disease: evidence from large-scale genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0934595a6a2e9c4e4edf812632d6bc4"><gtr:id>e0934595a6a2e9c4e4edf812632d6bc4</gtr:id><gtr:otherNames>Liu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5450a91f463650.02576417</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U123160651</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>